99 related articles for article (PubMed ID: 11867875)
1. Continuous renal replacement therapy. Keeping the circuit open: lessons from the lab.
Shulman RI; Singer M; Rock J
Blood Purif; 2002; 20(3):275-81. PubMed ID: 11867875
[TBL] [Abstract][Full Text] [Related]
2. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
Salmon J; Cardigan R; Mackie I; Cohen SL; Machin S; Singer M
Intensive Care Med; 1997 Jan; 23(1):38-43. PubMed ID: 9037638
[TBL] [Abstract][Full Text] [Related]
3. Clinical review: Patency of the circuit in continuous renal replacement therapy.
Joannidis M; Oudemans-van Straaten HM
Crit Care; 2007; 11(4):218. PubMed ID: 17634148
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
Kozek-Langenecker SA; Kettner SC; Oismueller C; Gonano C; Speiser W; Zimpfer M
Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
[TBL] [Abstract][Full Text] [Related]
5. Possible strategies to prolong circuit life during hemofiltration: three controlled studies.
Baldwin I; Tan HK; Bridge N; Bellomo R
Ren Fail; 2002 Nov; 24(6):839-48. PubMed ID: 12472205
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting circuit patency and filter 'life'.
Baldwin I
Contrib Nephrol; 2007; 156():178-84. PubMed ID: 17464125
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
[TBL] [Abstract][Full Text] [Related]
8. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
[TBL] [Abstract][Full Text] [Related]
9. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
10. Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
Blood Purif; 2015; 39(4):297-305. PubMed ID: 25966765
[TBL] [Abstract][Full Text] [Related]
11. A new form of myeloma "kidney": shortened hemofilter survival and implications for membrane filtration plasmapheresis.
Dana AP; Ahmar CA; Clapp WL; Ross EA
Clin Nephrol; 2011 Feb; 75(2):120-4. PubMed ID: 21255541
[TBL] [Abstract][Full Text] [Related]
12. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.
Palevsky PM; Burr R; Moreland L; Tokiwa Y; Greenberg A
ASAIO J; 1995; 41(4):847-9. PubMed ID: 8589465
[TBL] [Abstract][Full Text] [Related]
13. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
[TBL] [Abstract][Full Text] [Related]
14. Essentials of anticoagulation in hemodialysis.
Fischer KG
Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
Joannidis M; Kountchev J; Rauchenzauner M; Schusterschitz N; Ulmer H; Mayr A; Bellmann R
Intensive Care Med; 2007 Sep; 33(9):1571-9. PubMed ID: 17563874
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration.
Baldwin I; Tan HK; Bridge N; Bellomo R
Ren Fail; 2000 May; 22(3):297-306. PubMed ID: 10843240
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
[TBL] [Abstract][Full Text] [Related]
18. Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.
Mueller SW; MacLaren R; Fish DN; Kiser TH
Ann Pharmacother; 2009 Jul; 43(7):1360-5. PubMed ID: 19584380
[TBL] [Abstract][Full Text] [Related]
19. The effects of continuous venovenous hemofiltration on coagulation activation.
Bouman CS; de Pont AC; Meijers JC; Bakhtiari K; Roem D; Zeerleder S; Wolbink G; Korevaar JC; Levi M; de Jonge E
Crit Care; 2006; 10(5):R150. PubMed ID: 17069648
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
Nagarik AP; Soni SS; Adikey GK; Raman A
Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
